Part of Thermo Fisher Scientific
TREK Diagnostic Systems - Magellan Biosciences

 


Sitemap | Contact Info
  Products Technical Information Newsroom Company Information
Products
• Trade Shows
• Press Releases  
• Newsletters  
• Awards  
 

 

 

  

Press Releases
Browse through our latest news, and news archives.
 
 
 

Press Releases

2011
press release New FDA-Cleared Sensititre® OptiRead™ Automated Fluorometric Plate Reading System Provides Fast, Accurate MIC Plate Reads for Microbiology Laboratories
press release New FDA-Cleared Sensititre® AIM™ Automated Inoculation Delivery System Provides Faster, Accurate Dosing of MIC Plates for Microbiology Laboratories
press release Thermo Fisher Scientific Acquires TREK Diagnostic Systems
press release Magellan Biosciences Announces Agreement with Bruker to Provide Microbiology Tools to Battle Drug Resistance
press release Magellan Biosciences and Miacom Diagnostics Team Up to Enable Faster, Easier Identification of Pathogens as Part of Magellan’s End-to-End Suite of Microbiology Products Designed to Streamline Lab Workflow and Enable Better Treatment Decisions
   
2010
press release FDA Clears Three Additional Antimicrobials for Use on TREK Sensititre® In Vitro Diagnostic (IVD) MIC Susceptibility Plates: Minocycline and Telavancin Used to Treat MRSA and Other Infections; and Tigecycline, Now Cleared for Streptococcus Pneumoniae Testing
   
2009
press release TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products
press release Magellan Diagnostic Businesses to Feature Automated Systems and
Diagnostic Tests at Clinical Lab Expo
press release FDA Clears Caspofungin (Cancidas®) Susceptibility Testing for TREK Sensititre® YeastOne® in Vitro Diagnostics (IVD) Product Line
press release TREK to Introduce New In Vitro Diagnostic and Research-Use-Only Susceptibility Products at American Society for Microbiology General Meeting, Booth 130!
   
2008
press release TREK Diagnostic Systems Introduces First FDA-Cleared MIC Plate with D-Test and Cefoxitin Screen at the ASM 108th General Meeting
press release TREK Introduces First FDA-Cleared MIC Plate to Include D-Test and Cefoxitin Screen, Used in MRSA Detection
press release FDA Clears Doripenem for TREK Sensititre® In Vitro Dry Microbroth Plates used in Clinical-Diagnostic Laboratories
press release Sensititre® YeastOne® Now Includes Latest Antifungal Agents: Anidulafungin and Micafungin
   
 
  Archives: 2007 Press Releases
Archives: 2006 Press Releases
Archives: 2005 Press Releases
Archives: 2004 Press Releases

 

 
Sitemap | Privacy Policy | Terms & Conditions | © TREK Diagnostic Systems